Perimenopause pp 157-169 | Cite as

Gonadotropin Changes in the Perimenopause

  • Nancy E. Reame
Part of the Serono Symposia USA book series (SERONOSYMP)


It is widely accepted that the hallmark aging change in the menstrual cycle is an increase in basal follicle-stimulating hormone (FSH) levels in the face of normal luteinizing hormone (LH), presumably due to greater sensitivity of FSH to declining ovarian feedback on the hypothalamic-pituitary-ovarian (HPO) axis. The monotropic, age-related rise in FSH occurs as early as the mid-childbearing years when ovulations are still regular, but when the overall ovarian reserve of follicles begins to decline along with fertility rates. This view of the neuroendocrinology of reproductive aging is based on data from relatively few studies that have relied mainly on daily or weekly hormone measures. Although this work has provided global estimates of changes in the HPO axis, the underlying neuroendocrine and paracrine mechanisms responsible for these changes remain obscure. Thus, little is known about the dynamic secretory characteristics associated with the dysfunctional follicular development that typifies the perimenopause years, or the nature of the neuroendocrine signal responsible for the striking discordance in LH and FSH secretion.


Luteinizing Hormone Menstrual Cycle Follicular Phase Ovarian Reserve Luteinizing Hormone Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bachmann GA. The changes before “the change”: strategies for the transition to the menopause. Postgrad Med 1993;95:113–24.Google Scholar
  2. 2.
    World Health Organization. Research on the menopause. (Technical Report, Series 670.) Geneva, Switzerland, 1981.Google Scholar
  3. 3.
    Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967;12(1–2):77–126.PubMedGoogle Scholar
  4. 4.
    Jaffe RB. The menopause and perimenopausal period. In: Yen SSC, Jaffe RB, eds. Reproductive endocrinology, 3rd ed. Philadelphia: WB Saunders, 1991: 389–408.Google Scholar
  5. 5.
    Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604–6.PubMedGoogle Scholar
  6. 6.
    Ferin M, Jewelewicz R, Warren M. The last menstrual cycles: the climacteric and menopause. In: The menstrual cycle. Oxford University Press, 1993:92–104.Google Scholar
  7. 7.
    McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Am J Hum Biol 1992;4:37–46.CrossRefGoogle Scholar
  8. 8.
    Sherman BM, West JH, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 1975;55:699.PubMedCrossRefGoogle Scholar
  9. 9.
    Sherman BM, West JH, Korenman SG. The menopause transition: analysis of LH, FSH, estradiol and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 1976;52:629–36.CrossRefGoogle Scholar
  10. 10.
    Reyes FI, Winter JSD, Faiman C. Pituitary-ovarian relationships preceding the menopause. Am J Obstet Gynecol 1977;129:557–64.PubMedGoogle Scholar
  11. 11.
    Lee SJ, Lenton EA, Sexton L, Cooke ID. The effect of age on the cyclical patterns of plasma LH, FSH, estradiol and progesterone in women with regular menstrual cycles. Hum Reprod 1988;3:851–5.PubMedGoogle Scholar
  12. 12.
    Ebbiary A, Lenton EA, Cooke ID. Hypothalamic-pituitary aging: progressive increase in FSH and LH concentrations throughout the reproductive life in regularly menstruating women. Clin Endocrinol 1994;41:199–206.CrossRefGoogle Scholar
  13. 13.
    Metcalf MG, Donald RA. Fluctuating ovarian function in a perimenopausal woman. NZ Med J 1979;89:45–7.Google Scholar
  14. 14.
    US Congress. Office of Technology Assessment. The menopause, hormone therapy, and women’s health, OTA-BP-BA-88. Washington, DC: US Government Printing Office, May 1992.Google Scholar
  15. 15.
    Shideler SE, Devane GW, Kalra PS, Benirschke K, Lasley BL. Ovarian-pituitary hormone interactions during the perimenopause. Maturitas 1989;11:331–9.PubMedCrossRefGoogle Scholar
  16. 16.
    MacNaughton J, Bangah M, McCloud P, Hee J, Burger H. Age-related changes in follicle stimulating hormone, luteinizing hormone, estradiol and immunoreactive inhibin in women of reproductive age. Clin Endocrinol (Oxf) 1992; 36:339–45.CrossRefGoogle Scholar
  17. 17.
    Hee J, MacNaughton J, Bangah M, Burger H. Perimenopausal patterns of gonadotrophin, immunoreactive inhibin, estradiol and progesterone. Maturitas 1993;18:9–20.PubMedCrossRefGoogle Scholar
  18. 18.
    Buckler HM, Evans CA, Mamtora H, Burger HG, Anderson DC. Gonadotropin, steroid and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles. J Clin Endocrinol Metab 1991; 72:116–24.PubMedCrossRefGoogle Scholar
  19. 19.
    Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion at menopause. J Clin Endocrinol Metab 1987;65:1231–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Monroe SE, Jaffe RB, Midgley AR. Regulation of human gonadotropins. XIII. Changes in serum gonadotropins in menstruating women in response to oophorectomy. J Clin Endocrinol Metab 1972;34:420–2.PubMedCrossRefGoogle Scholar
  21. 21.
    Baird DT, Smith KB. Inhibin and related peptides in the regulation of reproduction. Oxf Rev Reprod Biol 1993;15:191–232.PubMedGoogle Scholar
  22. 22.
    DePaolo LV. Age-associated increases in serum follicle stimulating hormone levels in estrus are accompanied by a reduction in the ovarian secretion of inhibin. Exp Aging Res 1987;13:3.PubMedGoogle Scholar
  23. 23.
    Lambert-Messerlian GM, Hall JE, Sluss PM, et al. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site ELISA. J Clin Endocrinol Metab 1994;79:45–50.PubMedCrossRefGoogle Scholar
  24. 24.
    Petraglia F, Calza LI, Garuti GC, et al. Presence and synthesis of inhibin subunits in human decidua. J Clin Endocrinol Metab 1990;71:487–92.PubMedCrossRefGoogle Scholar
  25. 25.
    Groome NP, Lawrence M. Preparation of monoclonal antibodies to the beta A subunit of ovarian inhibin using a synthetic peptide immunogen. Hybridoma 1991;10:309–16.PubMedCrossRefGoogle Scholar
  26. 26.
    McConnell DS, Padmanabhan V, Pollak T, Groome NP, Ireland JJ, Midgley AR. Development of a two-site solid phase immunochemiluminescent assay for measurement of dimeric inhibin in biological fluids. 27th Annual Meeting of the Society for the Study of Reproduction, July 22, 1994.Google Scholar
  27. 27.
    Groome NP, O’Brien M, Illingworth P, et al. Inhibin-B is a major circulating form of inhibin in men and women. 77th Annual Meeting of the Endocrine Society, Washington DC, 1995; 103 (abstract #OR42–1).Google Scholar
  28. 28.
    Yen SSC, Tsai CC, Naftolin F, Vandenberg G, Ajabor L. Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J Clin Endocrinol Metab 1972;34:671–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Santen RJ, Bardin, CW. Episodic luteinizing hormone secretion in man. J Clin Invest 1973;52:2617.Google Scholar
  30. 30.
    Backstrom CT, McNeilly AS, Leask RM, Baird DT. Pulsatile secretion of LH, FSH, prolaetin, oestradiol and progesterone during the human menstrual cycle. Clin Endocrinol 1982; 17:29.CrossRefGoogle Scholar
  31. 31.
    Reame NE, Sauder SE, Kelch RP, Marshall JC. Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion. J Clin Endocrinol Metab 1984; 59:328.PubMedCrossRefGoogle Scholar
  32. 32.
    Wildt L, Hausler A, Marshall G, et al. Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey. Endocrinology 1981;109:376–85.PubMedCrossRefGoogle Scholar
  33. 33.
    Rossmanith WG, Reichelt C, Scherbaum WA. Neuroendocrinology of aging in humans: attenuated sensitivity to sex steroid feedback in elderly postmenopausal women. Neuroendocrinology 1994;59:355–62.PubMedCrossRefGoogle Scholar
  34. 34.
    Rossmanith WG, Liu CH, Laughlin GA, Mortola JF, Suh BY, Yen SSC. Relative changes in LH pulsatility during the menstrual cycle: using data from hypogonadal women as a reference point. Clin Endocrinol 1990;32:647–60.CrossRefGoogle Scholar
  35. 35.
    Veldhuis JD, Evans WS, Rogol AD, Thorner MO, Stumpf P. Actions of estradiol on discrete attributes of the luteinizing hormone pulse signal in man. J Clin Invest 1987;79:769–76.PubMedCrossRefGoogle Scholar
  36. 36.
    Cagnacci A, Melis GB, Paoletti AM, Gambacciani M, Soldani R, Spinetti A, et al. Influence of oestradiol and progesterone on pulsatile LH secretion in postmenopausal women. Clin Endocrinol (Oxf) 1989;31:541–50.CrossRefGoogle Scholar
  37. 37.
    D’Amico JF, Greendale GA, Lu JK, Judd HL. Induction of hypothalamic opioid activity with transdermal estradiol administration in postmenopausal women. Fertil Steril 1991;55:754–8.PubMedGoogle Scholar
  38. 38.
    Couzinet B, Lahlou N, Thomas G, et al. Effects of gonadotrophin releasing hormone antagonist and agonist on the pulsatile release of gonadotrophins and alpha-subunit in postmenopausal women. Clin Endocrinol (Oxf) 1991; 34:477–83.CrossRefGoogle Scholar
  39. 39.
    Rossmanith WG, Handke-Vesely A, Wirth U, Scherbaum WA. Does the gonadotropin pulsatility of postmenopausal women represent the unrestrained hypothalamic-pituitary activity? Eur J Endocrinol 1994;130:485–93.PubMedCrossRefGoogle Scholar
  40. 40.
    Reame NE, Yu MY, Zawacki C, Padmanabhan V, Beitins IZ, Kelch RP. Age effects on FSH and pulsatile LH secretion across the menstrual cycle of premenopausal women. J Clin Endocrinol Metab 1996; in press.Google Scholar
  41. 41.
    Burger HG, Dudley EC, Hopper JL, et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 1995;80:3537–45.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1997

Authors and Affiliations

  • Nancy E. Reame

There are no affiliations available

Personalised recommendations